FDA NDC Directory · JSON-LD · Markdown

Ganirelix Acetate

NDC 65219-028 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA215658
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsGANIRELIX ACETATE (250 ug/.5mL)
Marketing started20230324
Package count1

External sources

Source: openFDA. Public-domain (CC0).